BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21726937)

  • 21. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
    Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
    Mora J; Cheung NK; Chen L; Qin J; Gerald W
    Cancer; 2001 Jan; 91(2):435-42. PubMed ID: 11180092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
    Sanmartín E; Muñoz L; Piqueras M; Sirerol JA; Berlanga P; Cañete A; Castel V; Font de Mora J
    Clin Cancer Res; 2017 Nov; 23(22):6875-6887. PubMed ID: 28830922
    [No Abstract]   [Full Text] [Related]  

  • 25. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Leung SF; Choi PH; Fong Y; Lee JC; Huang DP
    Cancer Res; 1996 Jul; 56(14):3225-9. PubMed ID: 8764112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
    Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
    N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss.
    Hoshi M; Otagiri N; Shiwaku HO; Asakawa S; Shimizu N; Kaneko Y; Ohi R; Hayashi Y; Horii A
    Br J Cancer; 2000 Jun; 82(11):1801-7. PubMed ID: 10839294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
    Koreth J; Bakkenist CJ; McGee JO
    Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for involvement of SDHD in neuroblastoma pathogenesis.
    De Preter K; Vandesompele J; Hoebeeck J; Vandenbroecke C; Smet J; Nuyts A; Laureys G; Combaret V; Van Roy N; Roels F; Van Coster R; Praet M; De Paepe A; Speleman F
    BMC Cancer; 2004 Aug; 4():55. PubMed ID: 15331017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer.
    Tomlinson IP; Nicolai H; Solomon E; Bodmer WF
    J Pathol; 1996 Sep; 180(1):38-43. PubMed ID: 8943813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
    Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroblastoma in a boy with MCA/MR syndrome, deletion 11q, and duplication 12q.
    Koiffmann CP; Gonzalez CH; Vianna-Morgante AM; Kim CA; Odone-Filho V; Wajntal A
    Am J Med Genet; 1995 Jul; 58(1):46-9. PubMed ID: 7573155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.
    Davis M; Hitchcock A; Foulkes WD; Campbell IG
    Cancer Res; 1996 Feb; 56(4):741-4. PubMed ID: 8631007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity on chromosome arm 11q in lung carcinoids.
    Petzmann S; Ullmann R; Klemen H; Renner H; Popper HH
    Hum Pathol; 2001 Mar; 32(3):333-8. PubMed ID: 11274644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.